NCT00079014View on ClinicalTrials.gov

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

triapine

Given IV

DRUG

doxorubicin hydrochloride

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00079014 - 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter